Wellington Management Group LLP Raises Stake in OrthoPediatrics Corp. (NASDAQ:KIDS)

Wellington Management Group LLP raised its position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 16.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 883,221 shares of the company’s stock after purchasing an additional 122,846 shares during the quarter. Wellington Management Group LLP owned 3.65% of OrthoPediatrics worth $23,944,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Quarry LP purchased a new position in OrthoPediatrics during the third quarter valued at approximately $25,000. International Assets Investment Management LLC lifted its holdings in OrthoPediatrics by 2,610.8% during the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after purchasing an additional 966 shares in the last quarter. Quest Partners LLC purchased a new position in OrthoPediatrics during the second quarter valued at approximately $34,000. BNP Paribas Financial Markets lifted its holdings in OrthoPediatrics by 125.1% during the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock valued at $94,000 after purchasing an additional 1,929 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new position in OrthoPediatrics during the second quarter valued at approximately $110,000. Hedge funds and other institutional investors own 69.05% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Needham & Company LLC reiterated a “buy” rating and set a $42.00 price objective on shares of OrthoPediatrics in a research report on Friday, November 8th. Truist Financial reduced their price objective on shares of OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating on the stock in a research report on Monday, October 14th. Finally, JMP Securities reiterated a “market outperform” rating and set a $50.00 price objective on shares of OrthoPediatrics in a research report on Friday, September 13th.

OrthoPediatrics Trading Up 0.9 %

OrthoPediatrics stock opened at $22.12 on Friday. The firm’s 50 day moving average price is $25.47 and its 200-day moving average price is $28.51. OrthoPediatrics Corp. has a 1 year low of $21.02 and a 1 year high of $36.23. The stock has a market cap of $535.75 million, a P/E ratio of -17.98 and a beta of 1.14. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.